Impact of neoadjuvant immune checkpoint inhibitor therapy on primary tumor size and complexity: Correlation with surgical quality and short term oncological outcomes.
Year: 2022
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ava Saidian, Kevin Hakimi, Justine Panian, Archana Ajmera, Pedro C. Barata, Stephanie A. Berg, Steven Lee Chang, Toni K. Choueiri, Hannah Elizabeth Dzimitrowicz, Hamid Emamekhoo, Evan Gross, Deepak Kilari, Elaine Tat Lam, Taylor Nonato, Sarah P. Psutka, Bicky Thapa, Nicole Weise, Tian Zhang, Rana R. McKay, Ithaar Derweesh
Institutions: Moores Cancer Center, UC San Diego Health System, Tulane University, Loyola University Medical Center, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Duke University, Duke Cancer Institute, University of Wisconsin–Madison, University of Washington, Medical College of Wisconsin, University of Colorado Cancer Center, University of Colorado Anschutz, University of Washington Medical Center, Cleveland Clinic, University of California San Diego
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4212825151